PD-L1 (CD274) Human Monoclonal Antibody [Clone ID: LBI13D11]-抗体-抗体-生物在线
安诺伦(北京)生物科技有限公司
PD-L1 (CD274) Human Monoclonal Antibody [Clone ID: LBI13D11]

PD-L1 (CD274) Human Monoclonal Antibody [Clone ID: LBI13D11]

商家询价

产品名称: PD-L1 (CD274) Human Monoclonal Antibody [Clone ID: LBI13D11]

英文名称: PD-L1 (CD274) Human Monoclonal Antibody [Clone ID: LBI13D11]

产品编号: AMCH00005V

产品价格: null

产品产地: 美国

品牌商标: Leading Biology

更新时间: null

使用范围: FLOW 1:50~100

安诺伦(北京)生物科技有限公司
  • 联系人 :
  • 地址 : 北京大兴经济技术开发区天骥智谷35A
  • 邮编 :
  • 所在区域 : 北京
  • 电话 : 189****2642 点击查看
  • 传真 : 点击查看
  • 邮箱 : 3359689365@qq.com

别名:B7-H; B7H1; hPD-L1; PD-L1; PDCD1L1; PDCD1LG1; PDL1

产品概述:A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence

总结:This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]